| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.08 |